In contrast, female AML patients showed a significant reduction in the frequency of both ROShi MITOlo and GSHhi MITOlo CD34+ cells (p = 0.02 and p = 0.05, respectively; Fig. 1g). Here, CD34 is linked to acute myeloid leukemia.